Literature DB >> 2574749

Adherence of Pseudomonas aeruginosa to respiratory epithelium and the effect of leucocyte elastase.

M C Plotkowski1, G Beck, J M Tournier, M Bernardo-Filho, E A Marques, E Puchelle.   

Abstract

The tracheobronchial secretions from patients with cystic fibrosis often contain high amounts of free proteases. To evaluate whether human leucocyte elastase (HLE) can favour the persistence of bacterial airways infection, we exposed the frog palate mucosa to HLE and then to radiolabelled Pseudomonas aeruginosa and followed the sequence of events by scanning electronmicroscopy. In response to HLE there was a marked outpouring of mucus and a desquamation of the epithelium. P. aeruginosa was shown to adhere to recently secreted granules of mucus and to the exposed submucosal underlying connective tissues. For the eight different bacterial strains studied, a significative adherence to HLE-injured mucosa was observed only in strains that possessed internal haemagglutinating activity. Neither the presence of fimbriae, nor of the mucoid exopolysaccharide, nor of the bacterial surface haemagglutinating activity could be related to adherence of P. aeruginosa to the injured mucosa. These results support the hypothesis that HLE enhances bacterial infection of the respiratory mucosa both by inducing mucus hypersecretion and by exposing receptors to the microbial adhesins. It is also suggested that P. aeruginosa internal lectins may be implicated in adherence to host tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574749     DOI: 10.1099/00222615-30-4-285

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

Review 1.  Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

Authors:  N Høiby; C Koch
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

Review 2.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

3.  Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes.

Authors:  S Girod de Bentzmann; O Bajolet-Laudinat; F Dupuit; D Pierrot; C Fuchey; M C Plotkowski; E Puchelle
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  In vitro study of the bronchial mucosa during Pseudomonas aeruginosa infection.

Authors:  S Philippon; H J Streckert; K Morgenroth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Cytotoxicity of Pseudomonas aeruginosa internal lectin PA-I to respiratory epithelial cells in primary culture.

Authors:  O Bajolet-Laudinat; S Girod-de Bentzmann; J M Tournier; C Madoulet; M C Plotkowski; C Chippaux; E Puchelle
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.

Authors:  U Sajjan; J Reisman; P Doig; R T Irvin; G Forstner; J Forstner
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  Pseudomonas aeruginosa strains possess specific adhesins for laminin.

Authors:  M C Plotkowski; J M Tournier; E Puchelle
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

9.  Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture.

Authors:  M C Plotkowski; M Chevillard; D Pierrot; D Altemayer; J M Zahm; G Colliot; E Puchelle
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 10.  Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Authors:  Aurélie Crabbé; Maria A Ledesma; Cheryl A Nickerson
Journal:  Pathog Dis       Date:  2014-05-23       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.